| ［1］ |
Masri B，Knibiehler B，Audigier Y.Apelin signalling:a promising pathway from cloning to pharmacology［J］.Cell Signal，2005，17(4):415-426.
|
| ［2］ |
Lee DK，Cheng R，Nguyen T， et al.Characterization of apelin，the ligand for the APJ receptor［J］.J Neurochem，2000，74(1):34-41.
|
| ［3］ |
Hosoya M，Kawamata Y.Fukusumi S，et al.Molecular and functional characteristics of APJ.Tissue distribution of mRNA and interaction with the endogenous ligand Apelin［J］.J Biol Chem，2000，275(28):21061-21067.
|
| ［4］ |
李兰芳，封芬，潘伟男，等.APJ受体内源性配基apelin 的组织分布及对血压的影响［J］.中国现代医学杂志，2007，17(12):1442-1445.
|
| ［5］ |
Devic E，Rizzoti K，Bodin S，et al.Amino acid sequence and embryonic expression of msr/apj，the mouse homolog of Xenopus X-msr and human APJ［J］.Mech Dev，1999，84(l-2):199-203.
|
| ［6］ |
杨莉，陈临溪.Apelin/APJ系统对多个系统功能的调控作用［J］.国际病理科学与临床杂志，2011，31(1):42-44.
|
| ［7］ |
吴东红，王心珉，范小芳，等.慢性低氧高二氧化碳性肺动脉高压大鼠肺小血管尾加压素Ⅱ表达的动态变化［J］.中国微循环，2005，9(3):154-156.
|
| ［8］ |
Katugampola SD，Maguire JJ， Matthewson SR，et al.［(125) I］-［Pyr1］Apelin-13 is a novel radioligand for localizing the APJorphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man［J］.Br J Pharmacol，2001，132(6):1255-1260.
|
| ［9］ |
Szokodi I，Tavi P，Földes G，et al.Apelin，the novel endogenous ligand of the orphan receptor APJ，regulates cardiac contracility［J］.Circ Res，2002，91(5):434-440.
|
| ［10］ |
Ashley EA，Powers J，Chen M，et al.The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo［J］.Cardiovasc Res，2005，65(1):73-82.
|
| ［11］ |
Cheng X，Cheng XS，Pang CC.Venous dilator effect of apelin，an endogenous peptide ligand for the orphan APJ receptor， in conscious rats［J］.Eur JPharm acol，2003，470(3):171-175.
|
| ［12］ |
Brette F，Orchard C.T-tubule function in mammalian cardiac myocytes［J］.Circ Res，2003，92(11):1182-1192.
|
| ［13］ |
Hansen PB，Castrop H，Briggs J，et al.Adenosine induces vasocons triction through Gi-dependent activation of phospholipase Cinisolated perfused afferent arterioles of mice［J］.J Am Soc Nephrol，2003，14(10):2457-2465.
|
| ［14］ |
Tatemoto K，Hosoya M，Habata Y，et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor［J］.Biochem Biophys Res Commun，1998，251(2):471-476.
|
| ［15］ |
Jia YX，Lu ZF，Zhang J，et al.Apelin activates L-arginine/nitricoxide synthase/nitric oxide pathway in rat aortas［J］.Peptides，2007，28(10):2023-2029.
|
| ［16］ |
Lee DK，Saldivia VR，Nguyen T，et al.Modification of the terminal residue of apelin-13 antagonizes its hypotensive action［J］.Endocrinology，2005，146(1):231-236
|
| ［17］ |
贾月霞，曹军，齐永芬，等.Apelin 对异丙基肾上腺素诱导的大鼠心肌缺血性损伤的影响［J］.中国病理生理杂志，2005，21(12):2289-2294.
|
| ［18］ |
Chen MM，Ashley EA，Deng DX， et al.Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction［J］.Circulation，2003，108(12):1432-1439.
|
| ［19］ |
Földes G，Horkay F，Szokodi I，et al.Circulating and cardiac levels of apelin，the novel ligand of the orphan receptor APJ， in Patients with heart failure［J］.Biochem Biophys Res Commun，2003，308(3):480-485.
|
| ［20］ |
陈曦，赵永芳.丹参酮IIA对异丙肾上腺素致心肌缺血损伤大鼠apelin 及其受体的影响［J］.中国药物应用与监测，2012，9(1):18-21.
|
| ［21］ |
Bolli R.Cardio protective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research［J］.J Mol Cell Cardiol，2001，33(11):1897-1918.
|
| ［22］ |
Gonzalez FM，Shiva S，Vincent PS，et al.Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction［J］.Circulation，2008，117(23):2986-2994.
|
| ［23］ |
Kleinz MJ， Davenport AP.Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells［J］.Regul Pept， 2004，118(3):119-125.
|
| ［24］ |
Kleinz MJ，Skepper JN，Davenport AP.Immunocytochemical localisation of the Apelin receptor，APJ，to human cardiomyocytes.vascular smooth muscle and endothelial cells［J］.Regul Pept，2005，126(3):233-240.
|
| ［25］ |
Masri B，Morin N，Cornu M，et al.Apelin(65-77) activates P70 S6 kinase and is mitogenic for umbilical endothelial cells［J］.FASEB J，2004，18(15):1909-1911
|
| ［26］ |
Kasai A，Shintani N，Oda M，et.al.Apelin is a novel angiogenic factor in retinal endothelial cells［J］.Biochem Biophys Res Commun，2004，325(2):395-400.
|
| ［27］ |
Sorli SC，Le Gonidec S，Knibiehler B，et al.Apelin is a potent activator of tumour neoangiogenesis［J］.Oncogene，2007，26(55):7692-7699.
|
| ［28］ |
Cox CM，D'Agostino SL，Miller MK，et al.Apelin，the ligand for the endothelial G-protein-coupled receptor， APJ， is a potent angiogenic factor required for normal vascular development of the frog embryo［J］.Dev Biol，2006，296(1):177-189.
|
| ［29］ |
Kidoya H， Ueno M， Yamada Y， et al.Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis［J］.EMBO J，2008，27(3): 522-534.
|
| ［30］ |
Japp AG， Cruden NL， Amer DA， et al.Vascular effects of apelin in vivo in man［J］.J Am Coll Cardiol，2008，52(11):908-913.
|
| ［31］ |
Kunduzova O，Alet N，Delesque-Touchard N，et al.Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes［J］.FASEB J， 2008，22(12):4146-4153.
|
| ［32］ |
Eyries M，Siegfried G，Ciumas M，et al.Hypoxia-Induced Apelin expression regulates endothelial cell proliferation and regenerative angiogenesis［J］.Circ Res，2008，103(4):432-440.
|
| ［33］ |
Sun X，Iida S，Yoshikawa A，et al.Non-activated APJ suppresses the angiotensin II type 1 receptor，whereas Apelin-activated APJ acts conversely［J］.Hypertens Res，2011，34(6):701-716.
|
| ［34］ |
邓桂英，徐运.Apelin-APJ系统与血管发生［J］.国际脑血管病杂志，2010，18(10):797-800.
|
| ［35］ |
Bai B，Tang J，Liu H，et al.Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to Gi2 pathway［J］.Acta Biochim Biophys Sin (Shanghai)，2008，40(4):311-318.
|